» Articles » PMID: 21852081

COPD in the General Population: Prevalence, Incidence and Survival

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2011 Aug 20
PMID 21852081
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Worldwide, COPD is a leading cause of chronic morbidity and mortality. Although its prevalence is already well documented, very few studies have measured its incidence. We therefore investigated the prevalence, incidence and lifetime risk of COPD in the general population. In a population-based study including subjects ≥ 40, with 12 months of history available in the Dutch IPCI database, we identified COPD cases by a two-step validation algorithm. Among 185,325 participants with 601,283 years of follow-up, 7308 subjects with COPD were identified, and 1713 had incident COPD. The overall IR of physician-diagnosed COPD was 2.92/1000PY (95%CI 2.78-3.06). The incidence of COPD was higher in men (3.54; 95%CI 3.33-3.77) than in women (2.34; 95%CI 2.17-2.52), and the overall baseline prevalence of COPD was 3.02% (95%CI 2.94-3.10). For people who had entered the study free of COPD at the age of 40, the risk of developing COPD within the next 40 years was 12.7% for men and 8.3% for women. In patients with very severe COPD, 26% died after 1 year of follow-up, whereas 2.8% died among the non-COPD subjects. In the general population in the Netherlands, three on 1000 subjects were diagnosed with COPD per year. The incidence increased rapidly with age and was higher in men than in women. One in eight men and one in 12 women, being COPD free at the age of 40, will develop COPD during their further life. Mortality rates differed substantially between COPD patients and non-COPD subjects of the same age, underlining the burden of this disease.

Citing Articles

Trend of prevalence and characteristics of preserved ratio impaired spirometry (PRISm): Nationwide population-based survey between 2010 and 2019.

Choi H, Oak C, Jung M, Jang T, Nam S, Yoon T PLoS One. 2024; 19(7):e0307302.

PMID: 39042610 PMC: 11265705. DOI: 10.1371/journal.pone.0307302.


Differences in chronic obstructive pulmonary disease among US nursing home residents with heart failure according to sex and type of heart failure.

Osundolire S, Goldberg R, Lapane K Clin Respir J. 2023; 17(11):1130-1144.

PMID: 37712492 PMC: 10632080. DOI: 10.1111/crj.13698.


Effect of smoking on the development of chronic obstructive pulmonary disease in young individuals: a nationwide cohort study.

Chung C, Lee K, Han K, Shin D, Lee S Front Med (Lausanne). 2023; 10:1190885.

PMID: 37593403 PMC: 10428618. DOI: 10.3389/fmed.2023.1190885.


Predictors of Long-Term Survival of Thoracoscopic Lobectomy for Stage IA Non-Small Cell Lung Cancer: A Large Retrospective Cohort Study.

Gabryel P, Skrzypczak P, Campisi A, Kasprzyk M, Roszak M, Piwkowski C Cancers (Basel). 2023; 15(15).

PMID: 37568693 PMC: 10416904. DOI: 10.3390/cancers15153877.


Severe Emphysema Treated with Bilateral Lung Sealant: A Case Series with Long-Term Follow-Up.

Lindner C, Jensen K, Mortensen J, Kalhauge A, Jessen-Hansen H, Perch M Biomed Hub. 2023; 8(1):46-53.

PMID: 37405232 PMC: 10314992. DOI: 10.1159/000530490.